Current prospects of synthetic curcumin analogs and chalcone derivatives against Mycobacterium tuberculosis

Medicinal Chemistry

Volumn 9, Issue 7, 2013, Pages 897-903

  Bukhari, Syed Nasir Abbas ^a   Franzblau, Scott G ^b   Jantan, Ibrahim ^a   Jasamai, Malina ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Anti tubercular; Chalcones; Curcumin; Mycobacterium tuberculosis

Indexed keywords

CHALCONE DERIVATIVE; CURCUMIN;

ACYLATION; ALKYLATION; ANTITUBERCULAR ACTIVITY; DEMETHYLATION; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; MOLECULAR RECOGNITION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION;

ANTITUBERCULAR AGENTS; CHALCONE; CURCUMIN; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 84890266294     PISSN: 15734064     EISSN: 18756638     Source Type: Journal    
DOI: 10.2174/1573406411309070002     Document Type: Review

References (49)

1. Bogatcheva, E.; Hanrahan, C.; Nikonenko, B.; Samala, R.; Chen, P.; Gearhart, J.; Barbosa, F.; Einck, L.; Nacy, C.; Protopopova, M. Identification of new diamine scaffolds with activity against Mycobacterium tuberculosis. J. Med. Chem., 2006, 49 (11), 3045-48.
2. Janin, Y. Antituberculosis drugs: Ten years of research. Bioorg. Med. Chem., 2007, 15(7), 2479-2513.
3. Hanekom, M.; Gey van Pittius, N. C.; McEvoy, C.; Victor, T. C.; Van Helden, P. D.; Warren, R. M. Mycobacterium tuberculosis Beijing genotype: a template for success. Tuberculosis (Edinb)., 2011, 91(6), 510-523.
4. O'Brien, R. J.; Nunn, P. P. The need for new drugs against tuberculosis. Obstacles, opportunities, and next steps. Am. J. Respir. Crit. Care. Med., 2001, 163(5), 1055-8.
5. Barnes, P.; Bloch, A.; Davidson, P.; Snider DE, J. Tuberculosis in patients with human immunodeficiency virus infection. N. Engl. J. Med., 1991, 324(23), 1644-50.
6. Fujiwara, P.; Cook, S.; Rutherford, C.; Crawford, J.; Glickman, S.; Kreiswirth, B.; Sachdev, P.; Osahan, S.; Ebrahimzadeh, A.; Frieden, T. A continuing survey of drug-resistant tuberculosis, New York City, April 1994. Arch. Intern. Med., 1994, 157(5), 531-6.
7. Blair, I.; Mansilla Tinoco, R.; Brodie, M.; Clare, R.; Dollery, C.; Timbrell, J.; Beever, I. Plasma hydrazine concentrations in man after isoniazid and hydralazine administration. Human. Toxicol., 1985, 4(2), 195.
8. Dhar, D. N. The Chemistry of Chalcones and Related Compounds. Wiley: New York, 1981.
9. Raut, K.; Wendor, S. Synthesis of certain chalcones and 3-hydroxychromones. J. Org. Chem., 1960, 25(1), 50-52.
10. Inderlied, C.; Kemper, C.; Bermudez, L. The Mycobacterium avium complex. Clin. Microbiol. Rev., 1993, 6(3), 266-310.
11. Mandell, G. L.; Petri, W. A. J., Goodman and Gilman's The Pharmacological Basis of Therapeutics. McGraw Hill: New York, 1996.
12. Sensi, P.; Grassi, G. Burger's Medicinal Chemistry and Drug Discovery. John Wiley & Sons. Inc: New York, 1996.
13. Di Carlo, G.; Mascolo, N.; Izzo, A.; Capasso, F. Flavonoids: Old and New Aspects of a Class of Natural Therapeutic Drugs. Life. Sci., 1999, 65(4), 337-353.
14. Dimmock, J.; Elias, D.; Beazely, M.; Kandepu, N. Bioactivities of Chalcones. Curr. Med. Chem., 1999, 6(12), 1125-1149.
15. Ni, L.; Meng, Q. C.; Sikorski, J. A. Recent advances in therapeutic chalcones. Expert. Opin. Ther. Pat., 2004, 14(12), 1669-1691.
16. Nowakowska, Z. A review of anti-infective and anti-inflammatory chalcones. Eur. J. Med. Chem., 2007, 42,(2), 125-137.
17. Go, M.; Wu, X.; Liu, X. Chalcones: An update on cytotoxic and chemoprotective properties. Curr. Med. Chem., 2005, 12(4), 483-499.
18. Itokawa, H.; Shi, Q.; Akiyama, T.; Morris-Natschke, S.; Lee, K., Recent advances in the investigation of curcuminoids. Chin. Med., 2008, 3, 1-11.
19. Gupta, S.; Prasad, S.; Kim, J.; Patchva, S.; Webb, L.; Priyadarsini, I.; Aggarwal, B. Multitargeting by curcumin as revealed by molecular interaction studies. Nat. Prod. Rep., 2011, 28(12), 1937-55.
20. Kohli, K.; Ali, J.; Ansari, M.; Raheman, Z., Curcumin; a natural anti-inflammatory agent. Indian. J. Pharmacol., 2005, 37(3), 141-147.
21. Shakibaei, M. Suppression of NF-kB activation by curcumin leads to inhibition of expression of cyclooxygenase-2 and matrix metalloproteinase- 9 in human articular chondrocytes; Implications for the treatment of osteoarthritis. Biochem. Pharmacol., 2007, 73(9), 1434-1445.
22. Agrawal, B.; Sung, B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends. Pharmacol. Sci., 2009, 30, 85-94.
23. Aggarwal, B. Anticancer potential of curcumin preclinical and clinical studies. Anticancer. Res., 2003, 23, 363-398.
24. Allam, G. Immunomodulatory effects of curcumin treatment onmurine chistosomiasis mansoni. Immunobiology., 2009, 214, 712-727.
25. Gupta, S. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev., 2010, 29, 405-434.
26. Kumar, S.; Dubey, K.; Tripathi, S.; Fujii, M.; Misra, K. Design and synthesis of curcumin bioconjugates to improve systemic delivery. Nucleic Acids Symp. Ser., 2000,44 (1), 75-76.
27. Mishra, S.; Karmodiya, K.; Surolia, N.; Surolia, A. Synthesis and exploration of novel curcumin analogs as anti-malarial agents. Bioorg. Med. Chem., 2008, 16 (6), 2894-902.
28. Barthelemy, S.; Vergnes, L.; Moynier, M.; Guyot, D.; Labidalle, S.; Bahraoui, E. Curcumin and curcumin derivatives inhibit Tatmediated transactivation of type 1 human immunodeficiency virus long terminal repeat. Res. Virol., 1998, 149(1), 43-52.
29. Tong, Q. S.; Zheng, L. D.; Lu, P.; Jiang, F. C.; Chen, F. M.; Zeng, F. Q. Apoptosis-inducing effects of curcumin derivatives in human bladder cancer cells. Anti-cancer Drugs, 2006, 17 (3), 279-87.
30. Sharma, O. P., Antioxidant activity of curcumin and related compounds. Biochem. Pharmacol., 1976, 25(15), 1811-2.
31. Mishra, N.; Arora, P.; Kumar, B.; Mishra, L. C.; Bhattacharya, A.; Awasthi, S. K.; Bhasin, V. K. Synthesis of novel substituted 1,3-diaryl propenone derivatives and their antimalarial activity . Eur. J. Med. Chem., 2008, 43(7), 1530-1535.
32. Lin, Y.; Zhou, Y.; Flavin, M. T.; Zhou, L.; Nie, W.; Chen, F. Chalcones and Flavonoids as Anti-tuberculosis Agents. Bioorg. Med. Chem., 2002, 10(8), 2795-2802.
33. Chiaradia, L.; Mascarello, A.; Purificação, M.; Vernal, J.; Cordeiro, M.; Zenteno, M.; A, V.; Nunes, R.; Yunes, R.; Terenzi, H. Synthetic Chalcones as Efficient Inhibitors of Mycobacterium tuberculosis Protein Tyrosinephosphatase PtpA. Bioorg. Med. Chem. Lett., 2008, 18(23), 6227-6230.
34. Bach, H.; Papavinasasundaram, K.; Wong, D.; Hmama, Z.; Av-Gay, Y. Mycobacterium tuberculosis virulence is mediated by PtpA dephosphorylation of human vacuolar protein sorting 33B. Cell. Host. Microbe., 2008, 3(5), 316- 322.
35. Mascarello, A.; Chiaradia, L. D.; Vernal, J.; Villarino, A.; Guido, R. V. C.; Perizzolo, P.; Poirier, V.; Wong, D.; Martins, P. G. A.; Nunes, R. J.; Yunes, R. A.; Andricopulo, A. D.; Av-Gay, Y.; Terenzi, H. Inhibition of Mycobacterium tuberculosis tyrosine phosphatase PtpA by synthetic chalcones: Kinetics, molecular modeling, toxicityand effect on growth. Bioorg. Med. Chem., 2010, 18 (11), 3783-3789.
36. Hans, R.; Guantai, E.; Lategan, C.; Smith, P.; Wan, B.; Franzblau, S.; Gut, J.; Rosenthal, P.; Chibale, K. Synthesis, antimalarial and antitubercular activity of acetylenic acalcones. Bioorg. Med. Chem. Lett., 2010, 20(3), 942-944.
37. Maretina, I. A.; Trofimov, B. A. Enediyne antibiotics and their models: New potential of acetylene chemistry. Russ. Chem. Rev., 2006 75(9), 825-45.
38. Siddiq, A.; Dembitsky, V. Acetylenic anticancer agents. Anticancer Agents Med. Chem., 2008, 8(2), 132-170.
39. Deng, S.; Wang, Y.; Inui, T.; Chen, S.; Farnsworth, N.; Cho, S.; Franzblau, S.; Pauli, G. Anti-TB polyynes from the roots of angelica sinensis. Phytother. Res., 2008, 22(7), 878-82.
40. Sharma, M.; Chaturvedi, V.; Manju, Y. K.; Bhatnagar, S.; Srivastava, K.; Puri, S.; Chauhan, P. M. S. Substituted quinolinyl chalcones and quinolinyl pyrimidines as a new class of anti-infective agents. Eur. J. Med. Chem., 2009, 44(5), 2081-209.
41. Shaharyar, M.; Siddiqui, A. A.; Ali, M. A.; Sriram, D.; Yogeeswari, P. Synthesis and Antimycobacterial Activity of N1-nicotinoyl-3-(4′-hydroxy- 3′-methyl phenyl)- 5-[(sub)phenyl]-2-pyrazolines. Bioorg. Med. Chem. Lett., 2006, 16(15), 3947-49.
42. Anand, N.; Singh, P.; Sharma, A.; Tiwari, S.; Singh, V.; Singh, D.; Srivastava, K.; Singh, B.; Tripathi, R. Synthesis and evaluation of small libraries of triazolylmethoxy chalcones, flavanones and 2-aminopyrimidines as inhibitors of mycobacterial FAS-II and PknG. Bioorg. Med. Chem., 2012, 20(17), 5150-63.
43. Chiaradia, L.; Martins, P.; Cordeiro, M.; Guido, R.; Ecco, G.; Andricopulo, A.; Yunes, R.; Vernal, J.; Nunes, R.; Terenzi, H. Synthesis, biological evaluation, and molecular modeling of chalcone derivatives as potent inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatases (PtpA and PtpB). J. Med. Chem., 2012, 55(1), 390-402.
44. Hussain, M.; Ishwar Bhat, K.; Revanasiddappa, B. C.; Abubaker, S.; D.R, B. Antimicrobial and cytotoxic evaluation of (E)- Thienyl chalcones drived from Thiophene-2-Carbaldehyde. Pharmacologyonline, 2011, 3, 880-888.
45. Bhoot, D.; Ranjan, C.; Parekh, H. Synthesis and biological evaluation of chalcones and acetyl pyrazoline derivatives comprising furan nucleus as an antitubercular agents. Med. Chem. Res., 2012, 21(10), 3233-3239.
46. Rai, D.; Singh, J. K.; Roy, N.; Panda, D. Curcumin inhibits FtsZ assembly: an attractive mechanism for its antibacterial activity. Biochem. J., 2008, 410(1), 147-155.
47. Changtam, C.; Hongmanee, P.; Suksamrarn, A. Isoxazole analogs of curcuminoids with highly potent multidrug-resistant antimycobacterial activity. Eur. J. Med. Chem., 2010, 45(10), 4446-57.
48. Agrawal, D. K.; Saikia, D.; Tiwari, R.; Ojha, S.; Shanker, K.; Kumar, J. K.; Gupta, A. K.; Tandon, S.; Negi, A. S.; Khanuja, S. P. Demethoxycurcumin and its semisynthetic analogs as antitubercular agents. Planta. Med., 2008, 74(15), 1828.
49. Singh, M.; Sasi, P.; Gupta, V.; Rai, G.; Amarapurkar, D.; Wangikar, P. Protective effect of curcumin, silymarin and Nacetylcysteine on antitubercular drug-induced hepatotoxicity assessed in an model. Hum. Exp. Toxicol., 2012, 31(8), 788-797.